Cargando…
Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review
BACKGROUND: Esophagogastric junction adenocarcinomas (EGJAs) include esophageal and gastric cardia adenocarcinomas (GCAs). These tumors are currently regarded as a single entity, with similar surgical and oncological therapies, although they originate from different organs. Endoscopy allows an early...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210784/ https://www.ncbi.nlm.nih.gov/pubmed/35784626 http://dx.doi.org/10.20524/aog.2022.0719 |
_version_ | 1784730229036548096 |
---|---|
author | Doumbe-Mandengue, Paul Pellat, Anna Terris, Benoit Beuvon, Frédéric Leconte, Mahaut Dohan, Anthony Chaussade, Stanislas Coriat, Romain Barret, Maximilien |
author_facet | Doumbe-Mandengue, Paul Pellat, Anna Terris, Benoit Beuvon, Frédéric Leconte, Mahaut Dohan, Anthony Chaussade, Stanislas Coriat, Romain Barret, Maximilien |
author_sort | Doumbe-Mandengue, Paul |
collection | PubMed |
description | BACKGROUND: Esophagogastric junction adenocarcinomas (EGJAs) include esophageal and gastric cardia adenocarcinomas (GCAs). These tumors are currently regarded as a single entity, with similar surgical and oncological therapies, although they originate from different organs. Endoscopy allows an early-stage diagnosis, where both subtypes can be differentiated. With this review we aimed to describe the outcomes of endoscopic submucosal dissection for the treatment of esophageal adenocarcinomas (EAs) and GCAs. METHODS: We identified studies by screening PubMed, Embase and Web of Science. We included all 19 studies that mentioned at least one of the following criteria of interest: en bloc; R0 resection; local recurrences; and/or overall survival. RESULTS: We found an en bloc resection rate superior to 90% for both tumors. R0 resections rates were over 60% for most EAs, vs. 83% for most GCAs. We recorded less than 13% and 20% early and late adverse events for EA, and 10% and 7% for GCA. The local recurrence rate was 8% for EA and 3% for GCA. The overall survival was over 90%. CONCLUSIONS: Endoscopic submucosal dissection is safe and effective for esophageal and GCAs. These data support the extension of the use of endoscopic submucosal dissection to all EGJAs, including early EAs. |
format | Online Article Text |
id | pubmed-9210784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hellenic Society of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92107842022-07-01 Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review Doumbe-Mandengue, Paul Pellat, Anna Terris, Benoit Beuvon, Frédéric Leconte, Mahaut Dohan, Anthony Chaussade, Stanislas Coriat, Romain Barret, Maximilien Ann Gastroenterol Original Article BACKGROUND: Esophagogastric junction adenocarcinomas (EGJAs) include esophageal and gastric cardia adenocarcinomas (GCAs). These tumors are currently regarded as a single entity, with similar surgical and oncological therapies, although they originate from different organs. Endoscopy allows an early-stage diagnosis, where both subtypes can be differentiated. With this review we aimed to describe the outcomes of endoscopic submucosal dissection for the treatment of esophageal adenocarcinomas (EAs) and GCAs. METHODS: We identified studies by screening PubMed, Embase and Web of Science. We included all 19 studies that mentioned at least one of the following criteria of interest: en bloc; R0 resection; local recurrences; and/or overall survival. RESULTS: We found an en bloc resection rate superior to 90% for both tumors. R0 resections rates were over 60% for most EAs, vs. 83% for most GCAs. We recorded less than 13% and 20% early and late adverse events for EA, and 10% and 7% for GCA. The local recurrence rate was 8% for EA and 3% for GCA. The overall survival was over 90%. CONCLUSIONS: Endoscopic submucosal dissection is safe and effective for esophageal and GCAs. These data support the extension of the use of endoscopic submucosal dissection to all EGJAs, including early EAs. Hellenic Society of Gastroenterology 2022 2022-05-12 /pmc/articles/PMC9210784/ /pubmed/35784626 http://dx.doi.org/10.20524/aog.2022.0719 Text en Copyright: © Hellenic Society of Gastroenterology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Doumbe-Mandengue, Paul Pellat, Anna Terris, Benoit Beuvon, Frédéric Leconte, Mahaut Dohan, Anthony Chaussade, Stanislas Coriat, Romain Barret, Maximilien Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review |
title | Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review |
title_full | Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review |
title_fullStr | Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review |
title_full_unstemmed | Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review |
title_short | Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review |
title_sort | endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210784/ https://www.ncbi.nlm.nih.gov/pubmed/35784626 http://dx.doi.org/10.20524/aog.2022.0719 |
work_keys_str_mv | AT doumbemandenguepaul endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT pellatanna endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT terrisbenoit endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT beuvonfrederic endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT lecontemahaut endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT dohananthony endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT chaussadestanislas endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT coriatromain endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview AT barretmaximilien endoscopicsubmucosaldissectionforearlyesophagogastricjunctionadenocarcinomasasystematicreview |